Yes, if you're taking semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), liraglutide (Saxenda), or other GLP-1 receptor agonists
The FDA has been investigating post-marketing reports of mood changes on GLP-1 medications since 2023
BPC-157 is characterized for its activity at angiogenic and NO signaling pathways, while TB-500 is studied for its role in actin dynamics and cell migration
Doesn't that just mean "healthier foods?" I agree with the comments on this thread saying that a GLP-1 Friendly label would move consumers away from thinking in terms of healthier nutrition and give it too much of a pharmaceutical feel.
The probable cause of death was determined independently by both pathologists based on the severity of the pathology found at necropsy
The macro calculator gives you awareness, not homework